Replies to post #49995 on Ayala Pharmaceuticals Inc (ADXS)

[mm2k]

And I don't think the combo results with Keytruda are that critical. More important to get revenue, and the only way for that to happen is to get approval for AXAL. In the end, NEO will probably be much more important than anything else.

[gold007_2000]

We all know Keytruda is the number one cancer killer out there maybe, if combo data failed, i don't think other BP willing to PAY to collabrate with advaxis. Share price will tank to bottom, investors going to loose confidence over P3,dual, Neo everthing you can count on. as a result, company will struggle to raise money, on the brink of ruin again. of course we expect good PSA data. 2018 is very important year for Advaxis. Just my thoughts and opinion based on some bio stocks I track from last year.

[Mazo1]

There is no way that this company will go bankrupt or run out of money.Any company that is well run will have several contingencies in place before allowing that to take place.Also there is way to much money as well add lives at stake and we are to far along to allow that to happen,SO
. As far as I'm concerned the trial phases would be the only event that could bring Advaxis to its knees.And at this point in time,"there hasn't been any negative results"in regards to our trials. So sit back and enjoy the ride, everything will be just fine!!!